N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine
C49H67Cl3N12O4S — CID 158726572
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine
N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine (PubChem CID 158726572) has the molecular formula C49H67Cl3N12O4S and a molecular weight of 1026.58 g/mol. Its IUPAC name is N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine.
Molecular Properties
| Compound Name | N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine |
|---|---|
| PubChem CID | 158726572 |
| Molecular Formula | C49H67Cl3N12O4S |
| Molecular Weight | 1026.58 g/mol |
| Exact Mass | 1024.42 |
| IUPAC Name | N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine |
| SMILES | CC(=O)N(C)C1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C.CN(C1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C)S(C)(=O)=O.Clc1cc(N2CCC(N3CCOCC3)CC2)c2cn[nH]c2c1 |
| InChI | InChI=1S/C17H23ClN4O.C16H23ClN4O2S.C16H21ClN4O/c1-11(23)21(4)16-5-6-22(10-17(16,2)3)15-8-12(18)7-14-13(15)9-19-20-14;1-16(2)10-21(6-5-15(16)20(3)24(4,22)23)14-8-11(17)7-13-12(14)9-18-19-13;17-12-9-15-14(11-18-19-15)16(10-12)21-3-1-13(2-4-21)20-5-7-22-8-6-20/h7-9,16H,5-6,10H2,1-4H3,(H,19,20);7-9,15H,5-6,10H2,1-4H3,(H,18,19);9-11,13H,1-8H2,(H,18,19) |
| InChIKey | IKOOEFGPJYQYFI-UHFFFAOYSA-N |
| XLogP | 8.53 |
| TPSA | 165.92 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1026.58 |
| LogP ≤ 5 | 8.53 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158726572 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.